Cargando…

NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup

BACKGROUND: Hereditary Spastic Paraplegia (HSP) is a genetically heterogeneous group of neurodegenerative diseases. Thin Corpus Callosum (TCC) associated HSP is a distinguished subgroup of complex forms. Purines and pyrimidine, the basic DNA and RNA components, are regulating the cell metabolism, ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsaid, Mahmoud F., Ibrahim, Khalid, Chalhoub, Nader, Elsotouhy, Ahmed, El Mudehki, Noora, Abdel Aleem, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359868/
https://www.ncbi.nlm.nih.gov/pubmed/28327087
http://dx.doi.org/10.1186/s12881-017-0395-6
_version_ 1782516470825091072
author Elsaid, Mahmoud F.
Ibrahim, Khalid
Chalhoub, Nader
Elsotouhy, Ahmed
El Mudehki, Noora
Abdel Aleem, Alice
author_facet Elsaid, Mahmoud F.
Ibrahim, Khalid
Chalhoub, Nader
Elsotouhy, Ahmed
El Mudehki, Noora
Abdel Aleem, Alice
author_sort Elsaid, Mahmoud F.
collection PubMed
description BACKGROUND: Hereditary Spastic Paraplegia (HSP) is a genetically heterogeneous group of neurodegenerative diseases. Thin Corpus Callosum (TCC) associated HSP is a distinguished subgroup of complex forms. Purines and pyrimidine, the basic DNA and RNA components, are regulating the cell metabolism, having roles in signal transduction, energy preservation and cellular repair. Genetic defects in nucleotide metabolism related genes have been only recently implicated in brain and neurodegenerative diseases’ pathogenesis. CASE PRESENTATION: We present a consanguineous Qatari family with two brothers, 9 and 3 years, who displayed a characteristic phenotype of early onset and markedly-severe spasticity with tiptoe walking, delayed dysarthric speech, persistent truncal hypotonia, and multiple variable-sized areas of brownish skin discoloration appearing at different places on the body. A clinical diagnosis suggestive of complex hereditary spastic paraplegia (HSP) was set after the family had the second affected child. Whole genome sequencing identified a novel homozygous NT5C2 splice site mutation (NM_012229.4/NM_001134373.2: c.1159 + 1G > T) that recessively segregated in family members. Brain MRI revealed dysgenic and thin corpus callosum (TCC) with peri-trigonal white matter cystic changes in both affected boys, whereas a well-developed corpus callosum with normal white matter was shown in their apparently normal brother, who found to be a carrier for the mutant variant. This mutation led to skipping of exon 14 with removal of 58 amino acid residues at the C-terminal half. The aberrantly spliced NT5C2 showed substantial reduction in expression level in the in-vitro study, indicating marked instability of the mutant NT5C2 protein. CONCLUSION: The present report expands the phenotypic spectrum of SPG45 and confirms NT5C2-SPG45 as a member of the rare TCC SPG-subtypes. Homozygous alteration in NT5C2 seems essential to produce central white matter developmental defects. The study highlights the importance of cytosolic II 5’-nucleotidase (NT5C2) in maintaining the normal balance of purines’ pool in the brain, which seems to play a pivotal role in the normal development of central white matter structures. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-017-0395-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5359868
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53598682017-03-22 NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup Elsaid, Mahmoud F. Ibrahim, Khalid Chalhoub, Nader Elsotouhy, Ahmed El Mudehki, Noora Abdel Aleem, Alice BMC Med Genet Case Report BACKGROUND: Hereditary Spastic Paraplegia (HSP) is a genetically heterogeneous group of neurodegenerative diseases. Thin Corpus Callosum (TCC) associated HSP is a distinguished subgroup of complex forms. Purines and pyrimidine, the basic DNA and RNA components, are regulating the cell metabolism, having roles in signal transduction, energy preservation and cellular repair. Genetic defects in nucleotide metabolism related genes have been only recently implicated in brain and neurodegenerative diseases’ pathogenesis. CASE PRESENTATION: We present a consanguineous Qatari family with two brothers, 9 and 3 years, who displayed a characteristic phenotype of early onset and markedly-severe spasticity with tiptoe walking, delayed dysarthric speech, persistent truncal hypotonia, and multiple variable-sized areas of brownish skin discoloration appearing at different places on the body. A clinical diagnosis suggestive of complex hereditary spastic paraplegia (HSP) was set after the family had the second affected child. Whole genome sequencing identified a novel homozygous NT5C2 splice site mutation (NM_012229.4/NM_001134373.2: c.1159 + 1G > T) that recessively segregated in family members. Brain MRI revealed dysgenic and thin corpus callosum (TCC) with peri-trigonal white matter cystic changes in both affected boys, whereas a well-developed corpus callosum with normal white matter was shown in their apparently normal brother, who found to be a carrier for the mutant variant. This mutation led to skipping of exon 14 with removal of 58 amino acid residues at the C-terminal half. The aberrantly spliced NT5C2 showed substantial reduction in expression level in the in-vitro study, indicating marked instability of the mutant NT5C2 protein. CONCLUSION: The present report expands the phenotypic spectrum of SPG45 and confirms NT5C2-SPG45 as a member of the rare TCC SPG-subtypes. Homozygous alteration in NT5C2 seems essential to produce central white matter developmental defects. The study highlights the importance of cytosolic II 5’-nucleotidase (NT5C2) in maintaining the normal balance of purines’ pool in the brain, which seems to play a pivotal role in the normal development of central white matter structures. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-017-0395-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-21 /pmc/articles/PMC5359868/ /pubmed/28327087 http://dx.doi.org/10.1186/s12881-017-0395-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Elsaid, Mahmoud F.
Ibrahim, Khalid
Chalhoub, Nader
Elsotouhy, Ahmed
El Mudehki, Noora
Abdel Aleem, Alice
NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup
title NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup
title_full NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup
title_fullStr NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup
title_full_unstemmed NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup
title_short NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup
title_sort nt5c2 novel splicing variant expands the phenotypic spectrum of spastic paraplegia (spg45): case report of a new member of thin corpus callosum spg-subgroup
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359868/
https://www.ncbi.nlm.nih.gov/pubmed/28327087
http://dx.doi.org/10.1186/s12881-017-0395-6
work_keys_str_mv AT elsaidmahmoudf nt5c2novelsplicingvariantexpandsthephenotypicspectrumofspasticparaplegiaspg45casereportofanewmemberofthincorpuscallosumspgsubgroup
AT ibrahimkhalid nt5c2novelsplicingvariantexpandsthephenotypicspectrumofspasticparaplegiaspg45casereportofanewmemberofthincorpuscallosumspgsubgroup
AT chalhoubnader nt5c2novelsplicingvariantexpandsthephenotypicspectrumofspasticparaplegiaspg45casereportofanewmemberofthincorpuscallosumspgsubgroup
AT elsotouhyahmed nt5c2novelsplicingvariantexpandsthephenotypicspectrumofspasticparaplegiaspg45casereportofanewmemberofthincorpuscallosumspgsubgroup
AT elmudehkinoora nt5c2novelsplicingvariantexpandsthephenotypicspectrumofspasticparaplegiaspg45casereportofanewmemberofthincorpuscallosumspgsubgroup
AT abdelaleemalice nt5c2novelsplicingvariantexpandsthephenotypicspectrumofspasticparaplegiaspg45casereportofanewmemberofthincorpuscallosumspgsubgroup